On ECHEMI
Home > Drugs > Jiangsu Sihuan Bioengineering Pharmaceutical Co., Ltd.
Jiangsu Sihuan Bioengineering Pharmaceutical Co., Ltd.
  • Founded in:

    2011-11-15
  • Country:

    China China
  • Address:

    No. 10 Dingshan Road, Binjiang Development Zone, Jiangyin City
  • Tax NO.:

    91320281585574148F
  • Registered Funds:

    261 million yuan
  • Website:

  • Email:

Related Drugs
Ethamethamide injection
Phenolsulfonylamine, chemical name: 2,5-dihydroxybenzenesulfonic acid diethylamine salt
Name Description Content CAS NO. Registered Holders
Etamsylate

It can cause blood vessels to contract, reduce capillary permeability, enhance platelet aggregation and adhesion, promote platelets to release coagulation active substances, shorten coagulation time, and achieve hemostatic effect.

More

It can cause blood vessels to contract, reduce capillary permeability, enhance platelet aggregation and adhesion, promote platelets to release coagulation active substances, shorten coagulation time, and achieve hemostatic effect.

2624-44-4 11
Ethamethamide injection
Phenolsulfonylamine, chemical name: 2,5-dihydroxybenzenesulfonic acid diethylamine salt
Name Description Content CAS NO. Registered Holders
Etamsylate

It can cause blood vessels to contract, reduce capillary permeability, enhance platelet aggregation and adhesion, promote platelets to release coagulation active substances, shorten coagulation time, and achieve hemostatic effect.

More

It can cause blood vessels to contract, reduce capillary permeability, enhance platelet aggregation and adhesion, promote platelets to release coagulation active substances, shorten coagulation time, and achieve hemostatic effect.

2624-44-4 11
Levamisole Hydrochloride Tablets
The main ingredient of this product is: Levamisole hydrochloride. Its chemical name is: (S)-(-)-6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole hydrochloride.
Name Description Content CAS NO. Registered Holders
Levamisole hydrochloride

It selectively inhibits succinate dehydrogenase in the muscles of the worm, affects the anaerobic metabolism of the worm muscles, and reduces energy production; it depolarizes the nerve muscles, causing continuous muscle contraction and paralysis; its cholinergic effect is beneficial to the excretion of the worm; it may have an inhibitory effect on the microtubule structure of the worm; it has immune regulation and immune excitation functions.

More

It selectively inhibits succinate dehydrogenase in the muscles of the worm, affects the anaerobic metabolism of the worm muscles, and reduces energy production; it depolarizes the nerve muscles, causing continuous muscle contraction and paralysis; its cholinergic effect is beneficial to the excretion of the worm; it may have an inhibitory effect on the microtubule structure of the worm; it has immune regulation and immune excitation functions.

16595-80-5 7
Levamisole Hydrochloride Tablets
The main ingredient of this product is: Levamisole hydrochloride. Its chemical name is: (S)-(-)-6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole hydrochloride.
Name Description Content CAS NO. Registered Holders
Levamisole hydrochloride

This product is the levorotatory form of tetramisole, which can selectively inhibit succinate dehydrogenase in the muscles of the worm, so that fumaric acid cannot be reduced to succinic acid, thereby affecting the anaerobic metabolism of the muscles of the worm and reducing energy production. When the worm comes into contact with it, it can depolarize the nerves and muscles, and the muscles will continue to contract and cause paralysis; the drug's cholinergic effect is conducive to the excretion of the worm. Its activity is about 1 to 2 times that of tetramisole (racemic form), but its toxic side effects are lower. In addition, the drug may have an inhibitory effect on the microtubule structure of the worm. Levamisole also has immune regulation and immune preparation functions.

More

This product is the levorotatory form of tetramisole, which can selectively inhibit succinate dehydrogenase in the muscles of the worm, so that fumaric acid cannot be reduced to succinic acid, thereby affecting the anaerobic metabolism of the muscles of the worm and reducing energy production. When the worm comes into contact with it, it can depolarize the nerves and muscles, and the muscles will continue to contract and cause paralysis; the drug's cholinergic effect is conducive to the excretion of the worm. Its activity is about 1 to 2 times that of tetramisole (racemic form), but its toxic side effects are lower. In addition, the drug may have an inhibitory effect on the microtubule structure of the worm. Levamisole also has immune regulation and immune preparation functions.

16595-80-5 7
Pefloxacin Mesylate Injection
The main ingredient of this product is pefloxacin mesylate.
Name Description Content CAS NO. Registered Holders
Pefloxacin mesylate

Quinolone antibiotics exert broad-spectrum antibacterial effects by inhibiting bacterial DNA helicase. They have antibacterial activity against Enterobacteriaceae (such as Escherichia coli, Klebsiella, Proteus, Shigella, Salmonella typhi, etc.), influenza bacilli, Neisseria, Staphylococcus aureus and Pseudomonas aeruginosa, and have only mild effects on pneumococci, various groups of streptococci and enterococci.

More

Quinolone antibiotics exert broad-spectrum antibacterial effects by inhibiting bacterial DNA helicase. They have antibacterial activity against Enterobacteriaceae (such as Escherichia coli, Klebsiella, Proteus, Shigella, Salmonella typhi, etc.), influenza bacilli, Neisseria, Staphylococcus aureus and Pseudomonas aeruginosa, and have only mild effects on pneumococci, various groups of streptococci and enterococci.

70458-95-6 4
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.